drug development
See the following -
Significant Distortions Discovered in Leading Genetics Study Method - Open Source Software can Detect and Correct Them
Many conclusions drawn from a common approach to the study of human genetics could be distorted because of a previously overlooked phenomenon, according to researchers at the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai and collaborators from Massachusetts General Hospital and the Broad Institute. Their conclusions and a unique method they developed to help correct for this distortion were recently published in Nature Genetics.
- Login to post comments
Start Up Pharmaceutical Company Hallux Chooses ClinCapture As Their Electronic Data Capture Solution for Its Ease of Use, and Do-It-Yourself Tools
California-based pharmaceutical company Hallux Inc. selected ClinCapture as its Electronic Data Capture (EDC) system for its Do-It-Yourself study build features, ease of use and real time data exchange. ClinCapture is the only cloud-based, validated electronic data capture software, available for free. Startup pharmaceutical company Hallux develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis (toenail fungus). Having an EDC system that they could easily deploy, and fast, allowed Hallux to focus where it matters most: creating drugs that the community needs.
- Login to post comments
Telemedicine in Clinical Trials Highlighted At Upcoming Conferences
...At the Mobile and Clinical Trials Conference on September 10 and the 4th annual Dpharm: Disruptive Innovations in Clinical Trials Conference September 11-12, panelists will describe how telemedicine technology from AMC Health, a pioneer in providing telemedicine solutions for clinical trials, is being used to overcome these limitations...
- Login to post comments
The Lonely Universe Of Autoimmune Diseases
How would you feel if, after years of searching for a diagnosis you finally found out you have an autoimmune disease, and then you realize that your doctors will have to experiment on you to find the right treatment? That’s the state of the art today in autoimmune diseases like Crohn’s, lupus, and MS.
- Login to post comments
Top 10 Medical Research Trends To Watch In 2013
Congress has pushed the date of the "sequester" off another two months, delaying the prospect of automatic 8.2 percent cuts in the budgets of NIH, FDA, and other federal science programs. But a sequester (or other cuts) could still happen. [...] Read More »
- Login to post comments
TransCelerate Identifies Pharmacovigilance as an Operational Challenge in Need of Transformation
TransCelerate BioPharma Inc. today announced that it has added Pharmacovigilance to its portfolio, establishing two new global initiatives: 1.) Interpretation of Pharmacovigilance Regulations and 2.) Value of Safety Information Data Sources. Both initiatives aim to create solutions that will reduce resource inefficiencies, enhance information exchange with global health authorities and improve patient safety to drive more value for patients...
- Login to post comments
Transparency Life Sciences Awarded $1.4 Million NCATS SBIR Grant To Conduct Innovative Trial Of Lisinopril In Multiple Sclerosis
Transparency Life Sciences, LLC (TLS)...today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).
- Login to post comments
Transparency Life Sciences Launches Indication Finder™ Crowdsourcing Tool For Drug Repurposing
Transparency Life Sciences (TLS), the world's first drug development company based on open innovation, today announced the launch of Indication Finder™, a survey-based crowdsourcing tool designed to identify promising new indications for existing drug candidates. Read More »
- Login to post comments
Trial Designed With Crowd Input Gets FDA Signoff
What's been called the first clinical study protocol developed using crowdsourcing methods received the FDA's imprimatur earlier this month. The agency approved Transparency Life Sciences' IND for a clinical trial designed to test a generic blood-pressure medication, ACE inhibitor lisinopril, in patients with relapsing remitting multiple sclerosis. Read More »
- Login to post comments
UK Doubles Support for Neglected Tropical Diseases - To Protect 200 Million People
The UK will protect over 200 million people from the pain and disfigurement caused by treatable tropical diseases, International Development Secretary Priti Patel announced today. Neglected Tropical Diseases, such as trachoma, Guinea worm and river blindness, are avoidable infections but can deform, disable, blind and even kill if left untreated. They affect over a billion people in the poorest and most marginalised communities in the world, stopping children going to school and parents going to work - costing developing economies billions of dollars every year in lost productivity and reducing overall global prosperity...
- Login to post comments
Using Patient-centered Technology To Improve Recruitment And Retention
Sponsors of clinical research must increasingly focus on improving patient engagement in order to meet many of today’s research challenges. Promising disruptions are already under way that could define new models for patient recruitment and retention. Read More »
- Login to post comments
Using Scientific Publications Strategy to Ensure a Pharmaceutical Company's Credibility and a Product's Viability
Scientific publications remain the principal way that biopharmaceutical organizations relay critical clinical trial data to key external stakeholders such as physicians and payers. Data from different phases of drug development are the earliest ways these stakeholders learn about new products and the information serves as the building blocks for how a new product will be positioned in the marketplace...
- Login to post comments
VA Researchers Testing Cheaper Clinical Trials Using Tech
Clinicians across more than 30 VA medical centers are taking part in a $10 million randomized clinical trial meant to compare two common treatments for hypertension. These doctors will not, however, noticeably change how they treat their patients or how they collect data about them. In fact, after veterans are enrolled in the trial, they will be asked to continue managing their blood pressure using their regular doctors, unlike in the vast majority of clinical trials where new doctors treat patients and study staff oversee them...
- Login to post comments
Why Chemotherapy That Costs $70,000 In The U.S. Costs $2,500 In India
By rejecting patent applications, developing countries have kept down the costs of much-needed medications. Can they continue to do so without harming efforts to develop new drugs? Read More »
- Login to post comments
‘Superbug’ Scourge Spreads as U.S. Fails to Track Rising Human Toll
Fifteen years after the U.S. declared drug-resistant infections to be a grave threat, the crisis is only worsening, a Reuters investigation finds, as government agencies remain unwilling or unable to impose reporting requirements on a healthcare industry that often hides the problem...
- Login to post comments